PubMed

Divergent pathways of gene expression are activated by the RAGE ligands S100b and AGE-BSA.

Valencia JV, Mone M, Zhang J, Weetall M, Buxton FP, Hughes TE.

Diabetes. 2004 Mar;53(3):743-51.PMID: 14988260 [PubMed - indexed for MEDLINE]Related articlesFree article

Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products.

Valencia JV, Mone M, Koehne C, Rediske J, Hughes TE.

Diabetologia. 2004 May;47(5):844-52. Epub 2004 May 1.PMID: 15127201 [PubMed - indexed for MEDLINE]Related articles

AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression.

Boulanger E, Wautier MP, Wautier JL, Boval B, Panis Y, Wernert N, Danze PM, Dequiedt P.

Kidney Int. 2002 Jan;61(1):148-56.PMID: 11786095 [PubMed - indexed for MEDLINE]Related articlesFree article

Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in human monocytes.

Figarola JL, Shanmugam N, Natarajan R, Rahbar S.

Diabetes. 2007 Mar;56(3):647-55.PMID: 17327432 [PubMed - indexed for MEDLINE]Related articlesFree article

Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products.

Shanmugam N, Kim YS, Lanting L, Natarajan R.

J Biol Chem. 2003 Sep 12;278(37):34834-44. Epub 2003 Jun 30.PMID: 12837757 [PubMed - indexed for MEDLINE]Related articlesFree article

Differential effects between amphoterin and advanced glycation end products on colon cancer cells.

Kuniyasu H, Chihara Y, Kondo H.

Int J Cancer. 2003 May 10;104(6):722-7.PMID: 12640679 [PubMed - indexed for MEDLINE]Related articles

Advanced glycation end-products (AGEs) induce concerted changes in the osteoblastic expression of their receptor RAGE and in the activation of extracellular signal-regulated kinases (ERK).

Cortizo AM, Lettieri MG, Barrio DA, Mercer N, Etcheverry SB, McCarthy AD.

Mol Cell Biochem. 2003 Aug;250(1-2):1-10.PMID: 12962137 [PubMed - indexed for MEDLINE]Related articles

Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.

Valencia JV, Weldon SC, Quinn D, Kiers GH, DeGroot J, TeKoppele JM, Hughes TE.

Anal Biochem. 2004 Jan 1;324(1):68-78.PMID: 14654047 [PubMed - indexed for MEDLINE]Related articles

Grape seed proanthocyanidin extracts inhibit vascular cell adhesion molecule expression induced by advanced glycation end products through activation of peroxisome proliferators-activated receptor gamma.

Ma L, Gao HQ, Li BY, Ma YB, You BA, Zhang FL.

J Cardiovasc Pharmacol. 2007 May;49(5):293-8.PMID: 17513948 [PubMed - indexed for MEDLINE]Related articles

Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells.

Reddy MA, Li SL, Sahar S, Kim YS, Xu ZG, Lanting L, Natarajan R.

J Biol Chem. 2006 May 12;281(19):13685-93. Epub 2006 Mar 21.PMID: 16551628 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.

Zhang FL, Gao HQ, Shen L.

J Cardiovasc Pharmacol. 2007 Oct;50(4):434-40.PMID: 18049312 [PubMed - indexed for MEDLINE]Related articles

RAGE ligand upregulation of VEGF secretion in ARPE-19 cells.

Ma W, Lee SE, Guo J, Qu W, Hudson BI, Schmidt AM, Barile GR.

Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1355-61.PMID: 17325184 [PubMed - indexed for MEDLINE]Related articlesFree article

Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation.

Yamagishi S, Takeuchi M.

Drugs Exp Clin Res. 2004;30(4):169-75.PMID: 15553663 [PubMed - indexed for MEDLINE]Related articles

Telmisartan inhibits advanced glycation end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gammaactivation.

Yamagishi S, Matsui T, Nakamura K, Takeuchi M, Inoue H.

Protein Pept Lett. 2008;15(8):850-3.PMID: 18855759 [PubMed - indexed for MEDLINE]Related articles

Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.

Yamagishi S, Matsui T, Nakamura K, Yoshida T, Takeuchi M, Inoue H, Yoshida Y, Imaizumi T.

Ophthalmic Res. 2007;39(2):92-7. Epub 2007 Feb 2.PMID: 17284935 [PubMed - indexed for MEDLINE]Related articles

The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha.

Lohwasser C, Neureiter D, Weigle B, Kirchner T, Schuppan D.

J Invest Dermatol. 2006 Feb;126(2):291-9.PMID: 16374460 [PubMed - indexed for MEDLINE]Related articlesFree article

Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation.

Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R, Rauvala H.

J Biol Chem. 2000 Dec 22;275(51):40096-105.PMID: 11007787 [PubMed - indexed for MEDLINE]Related articlesFree article

Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses.

Basta G, Lazzerini G, Massaro M, Simoncini T, Tanganelli P, Fu C, Kislinger T, Stern DM, Schmidt AM, De Caterina R.

Circulation. 2002 Feb 19;105(7):816-22.PMID: 11854121 [PubMed - indexed for MEDLINE]Related articlesFree article

Interaction of Nepsilon(carboxymethyl)lysine- and methylglyoxal-modified albumin with endothelial cells and macrophages. Splice variants of RAGE may limit the responsiveness of human endothelial cells to AGEs.

Lieuw-a-Fa ML, Schalkwijk CG, Engelse M, van Hinsbergh VW.

Thromb Haemost. 2006 Feb;95(2):320-8.PMID: 16493495 [PubMed - indexed for MEDLINE]Related articles

Expression of platelet-endothelial cell adhesion molecule-1 in human umbilical vein endothelial cells by exposure to advanced glycosylation end products and inflammatory mediators.

Meng D, Liu N.

Chin Med J (Engl). 2003 Sep;116(9):1336-40.PMID: 14527361 [PubMed - indexed for MEDLINE]Related articlesFree article